RESEARCH TRIANGLE PARK, N.C. and SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (GTHX) (Nasdaq: GTHX), a commercial-stage oncology company, and Deimos Biosciences, a portfolio ...
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
RESEARCH TRIANGLE PARK, N.C. and BOSTON, May 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (GTHX) (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics ...
RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced a license agreement for ...
RESEARCH TRIANGLE PARK, N.C., U.S, and NANJING, China, Aug. 03, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, and ...
A driver has been charged with impaired operation by police in Toronto after she was stopped allegedly over the limit with a two-year-old in the car. In a post on social media, Ontario Provincial ...
On Tuesday, police charged the driver with stunt driving and G1 licence offences. They didn’t provide the age or sex of the driver, who received a seven-day licence suspension and a 14-day vehicle ...
- G1 to receive $6 million upfront payment, sales royalties and up to $40 million in future milestone payments- Genor to lead clinical development, regulatory submissions and commercialization of ...
Recently, I attended a local community meeting that, among other police-related topics, dealt with some neighbourhood traffic issues. At the end of the meeting, I was approached by a woman who seemed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback